Cargando…
In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2
Engineered red blood cells (RBCs) expressing viral receptors could be used therapeutically as viral traps, as RBCs lack nuclei and other organelles required for viral replication. However, expression of viral receptors on RBCs is difficult to achieve since mature erythrocytes lack the cellular machi...
Autores principales: | Hoffmann, Magnus A.G., Kieffer, Collin, Bjorkman, Pamela J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944778/ https://www.ncbi.nlm.nih.gov/pubmed/33723514 http://dx.doi.org/10.1016/j.omtm.2021.03.003 |
Ejemplares similares
-
Longitudinal imaging of HIV-1 spread in humanized mice with parallel 3D immunofluorescence and electron tomography
por: Kieffer, Collin, et al.
Publicado: (2017) -
Mechanisms of virus dissemination in bone marrow of HIV-1–infected humanized BLT mice
por: Ladinsky, Mark S, et al.
Publicado: (2019) -
Electron Tomography of HIV-1 Infection in Gut-Associated Lymphoid Tissue
por: Ladinsky, Mark S., et al.
Publicado: (2014) -
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020) -
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
por: Glasgow, Anum, et al.
Publicado: (2020)